Engineering Biomimetic Nanosystem Targeting Multiple Tumor Radioresistance Hallmarks for Enhanced Radiotherapy

Overview

Journal Sci China Life Sci

Specialties Biology
Science

Date 2024 Apr 11

PMID 38602587

Authors

Shuxiang Wang

Hongmei Cao

Cui-Cui Zhao

Qian Wang

Dianyu Wang

Jinjian Liu

Lijun Yang

Jianfeng Liu

Affiliations

Soon will be listed here.

Abstract

Tumor cells establish a robust self-defense system characterized by hypoxia, antioxidant overexpression, DNA damage repair, and so forth to resist radiotherapy. Targeting one of these features is insufficient to overcome radioresistance due to the feedback mechanisms initiated by tumor cells under radiotherapy. Therefore, we herein developed an engineering biomimetic nanosystem (M@HHPt) masked with tumor cell membranes and loaded with a hybridized protein-based nanoparticle carrying oxygens (O) and cisplatin prodrugs (Pt(IV)) to target multiple tumor radioresistance hallmarks for enhanced radiotherapy. After administration, M@HHPt actively targeted and smoothly accumulated in tumor cells by virtue of its innate homing abilities to realize efficient co-delivery of O and Pt(IV). O introduction induced hypoxia alleviation cooperated with Pt(IV) reduction caused glutathione consumption greatly amplified radiotherapy-ignited cellular oxidative stress. Moreover, the released cisplatin effectively hindered DNA damage repair by crosslinking with radiotherapy-produced DNA fragments. Consequently, M@HHPt-sensitized radiotherapy significantly suppressed the proliferation of lung cancer H1975 cells with an extremely high sensitizer enhancement ratio of 1.91 and the progression of H1975 tumor models with an excellent tumor inhibition rate of 94.7%. Overall, this work provided a feasible strategy for tumor radiosensitization by overcoming multiple radioresistance mechanisms.

References

Awuah S, Riddell I, Lippard S . Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity. Proc Natl Acad Sci U S A. 2017; 114(5):950-955. PMC: 5293106. DOI: 10.1073/pnas.1615327114. View

Bailly A, Correard F, Popov A, Tselikov G, Chaspoul F, Appay R . In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles. Sci Rep. 2019; 9(1):12890. PMC: 6734012. DOI: 10.1038/s41598-019-48748-3. View

Barker H, Paget J, Khan A, Harrington K . The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015; 15(7):409-25. PMC: 4896389. DOI: 10.1038/nrc3958. View

Birben E, Sahiner U, Sackesen C, Erzurum S, Kalayci O . Oxidative stress and antioxidant defense. World Allergy Organ J. 2012; 5(1):9-19. PMC: 3488923. DOI: 10.1097/WOX.0b013e3182439613. View

Buckley A, Lynam-Lennon N, ONeill H, OSullivan J . Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers. Nat Rev Gastroenterol Hepatol. 2020; 17(5):298-313. DOI: 10.1038/s41575-019-0247-2. View

Cai J, Xu X, Saw P . Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance. Sci China Life Sci. 2023; 67(1):19-40. DOI: 10.1007/s11427-022-2340-4. View

Cao H, Gao Y, Jia H, Zhang L, Liu J, Mu G . Macrophage-Membrane-Camouflaged Nonviral Gene Vectors for the Treatment of Multidrug-Resistant Bacterial Sepsis. Nano Lett. 2022; 22(19):7882-7891. DOI: 10.1021/acs.nanolett.2c02560. View

Chen Y, Li Y, Huang L, Du Y, Gan F, Li Y . Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev. 2021; 2021:6620306. PMC: 7884184. DOI: 10.1155/2021/6620306. View

Chen Z, Liu L, Liang R, Luo Z, He H, Wu Z . Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect. ACS Nano. 2018; 12(8):8633-8645. DOI: 10.1021/acsnano.8b04371. View

10.

Chowdhury D, Keogh M, Ishii H, Peterson C, Buratowski S, Lieberman J . gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell. 2005; 20(5):801-9. DOI: 10.1016/j.molcel.2005.10.003. View

11.

de Vries G, Rosas-Plaza X, van Vugt M, Gietema J, de Jong S . Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat Rev. 2020; 88:102054. DOI: 10.1016/j.ctrv.2020.102054. View

12.

Dong Z, Feng L, Chao Y, Hao Y, Chen M, Gong F . Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy. Nano Lett. 2018; 19(2):805-815. DOI: 10.1021/acs.nanolett.8b03905. View

13.

Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P . A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems. RSC Adv. 2022; 10(45):26777-26791. PMC: 9055574. DOI: 10.1039/d0ra03491f. View

14.

Fang R, Gao W, Zhang L . Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2022; 20(1):33-48. DOI: 10.1038/s41571-022-00699-x. View

15.

Fu S, Li Z, Xiao L, Hu W, Zhang L, Xie B . Glutamine Synthetase Promotes Radiation Resistance via Facilitating Nucleotide Metabolism and Subsequent DNA Damage Repair. Cell Rep. 2019; 28(5):1136-1143.e4. DOI: 10.1016/j.celrep.2019.07.002. View

16.

Gao Y, Wang K, Zhang J, Duan X, Sun Q, Men K . Multifunctional nanoparticle for cancer therapy. MedComm (2020). 2023; 4(1):e187. PMC: 9834710. DOI: 10.1002/mco2.187. View

17.

Gil Del Alcazar C, Todorova P, Habib A, Mukherjee B, Burma S . Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma. Mol Cancer Res. 2016; 14(10):928-940. PMC: 5065752. DOI: 10.1158/1541-7786.MCR-16-0125. View

18.

Gupta P, Fillmore C, Jiang G, Shapira S, Tao K, Kuperwasser C . Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 2011; 146(4):633-44. DOI: 10.1016/j.cell.2011.07.026. View

19.

Holohan C, Van Schaeybroeck S, Longley D, Johnston P . Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013; 13(10):714-26. DOI: 10.1038/nrc3599. View

20.

Hu C, Wang L, Chodosh L, Keith B, Simon M . Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 2003; 23(24):9361-74. PMC: 309606. DOI: 10.1128/MCB.23.24.9361-9374.2003. View